Skip to main content
. 2023 Sep 6;40:100898. doi: 10.1016/j.lanwpc.2023.100898

Fig. 3.

Fig. 3

Bar chart showing the percentage of patients with strong TGFβ1 suppression (low week 8/baseline level) among patients with HPD vs non-HPD progressors vs non-progressors (per RECIST v1.1). Abbreviations: HPD: Hyper-progression; Non-HPD progressors, progressive disease not fulfilling the definition of HPD; Non-progressors = complete response (CR) + partial response (PR) + stable disease (SD).